Mitochondrial Transplantation Alleviates Doxorubicin-Induced Toxicity in Rat Renal Cells
Iranian Journal of Pharmaceutical Research · 31.03.2024 · 23 (1)
DOI: 10.5812/ijpr-146033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 31.03.2024. Verfasst von Enayatollah Seydi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Health and Safety Engineering, School of Health, Alborz University of Medical Sciences, Karaj, Iran. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Doxorubicin (DOX) is used in the treatment of various cancers and has good effectiveness. However, its therapeutic use is limited due to its effects on various organs and healthy cells. Doxorubicin can affect the kidneys and cause toxicity. Evidence shows that DOX induces nephrotoxicity through oxidative stress.
Objectives
In this research, we examined the effect of mitochondrial transplantation on improving mitochondrial and cellular toxicity caused by DOX on renal proximal tubular cells (RPTCs).
Methods
The research measured 7 toxicity parameters, including cell lysis, reactive oxygen species (ROS) formation, mitochondrial membrane potential (MMP) decline, GSH and GSSG content, lipid peroxidation (LPO), adenosine triphosphate (ATP) content, and Caspase-3 activity (the final mediator of apoptosis). Active fresh mitochondria were prepared from Wistar rat kidney.
Results
The findings indicated that DOX caused cytotoxicity in RPTCs. Additionally, DOX induced oxidative stress by increasing the level of reactive oxygen species, reducing glutathione content, and elevating lipid peroxidation. Moreover, it led to damage to the mitochondrial membrane, increased caspase-3 activity, and decreased ATP content. Mitochondrial transplantation, as a new therapeutic approach, reduced oxidative stress, mitochondrial membrane damage, and apoptosis caused by DOX in RPTCs. Furthermore, this therapeutic approach increased the ATP content in RPTCs.
Conclusions
Our study suggests that this therapeutic approach could be helpful in the treatment of drug-induced nephrotoxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Occupational Health and Safety Engineering, School of Health, Alborz University of Medical Sciences, Karaj, Iran.
- Research Center for Health, Safety and Environment, Alborz University of Medical Sciences, Karaj, Iran.
- School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- School of Pharmacy, Eastern Mediterranean University, Famagusta, North Cyprus.
Zitieren
APA
Seydi, E., Andalib, M., Yaghoubi, S., Fakhri, A., Yuzugulen, J., Arjmand, A., & Pourahmad, J. (2024). Mitochondrial Transplantation Alleviates Doxorubicin-Induced Toxicity in Rat Renal Cells. Iranian Journal of Pharmaceutical Research, 23(1). https://doi.org/10.5812/ijpr-146033
Vancouver
Seydi E, Andalib M, Yaghoubi S, Fakhri A, Yuzugulen J, Arjmand A, et al. Mitochondrial Transplantation Alleviates Doxorubicin-Induced Toxicity in Rat Renal Cells. Iranian Journal of Pharmaceutical Research. 2024;23(1). doi:10.5812/ijpr-146033
BibTeX
@article{Seydi2024,
author = {Seydi, Enayatollah and Andalib, Mahsa and Yaghoubi, Sana and Fakhri, Amir and Yuzugulen, Jale and Arjmand, Abdollah and Pourahmad, Jalal},
title = {Mitochondrial Transplantation Alleviates Doxorubicin-Induced Toxicity in Rat Renal Cells},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2024},
volume = {23},
number = {1},
doi = {10.5812/ijpr-146033}
}
EUVIMED